Previously, PC‐mAb was shown to reduce CCL2 levels produced by human monocytes stimulated with oxLDL in vitro and regarding accelerated atherosclerosis local expression of CCL2 in the vessel wall was inhibited.39 Here, CCL2 is linked to atherosclerosis.